0001209191-20-034676.txt : 20200605 0001209191-20-034676.hdr.sgml : 20200605 20200605160513 ACCESSION NUMBER: 0001209191-20-034676 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200603 FILED AS OF DATE: 20200605 DATE AS OF CHANGE: 20200605 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Allen Patricia L CENTRAL INDEX KEY: 0001348587 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38219 FILM NUMBER: 20946136 BUSINESS ADDRESS: BUSINESS PHONE: 978-687-6988 MAIL ADDRESS: STREET 1: 7 ASHFORD LANE CITY: ANDOVER STATE: MA ZIP: 01810 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Deciphera Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001654151 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 200299725 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 200 SMITH STREET CITY: WALTHAM STATE: MA ZIP: 02451 BUSINESS PHONE: 781-209-6400 MAIL ADDRESS: STREET 1: 200 SMITH STREET CITY: WALTHAM STATE: MA ZIP: 02451 FORMER COMPANY: FORMER CONFORMED NAME: Deciphera Pharmaceuticals, LLC DATE OF NAME CHANGE: 20150928 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-06-03 0 0001654151 Deciphera Pharmaceuticals, Inc. DCPH 0001348587 Allen Patricia L C/O DECIPHERA PHARMACEUTICALS, INC. 200 SMITH STREET WALTHAM MA 02451 1 0 0 0 Common Stock 2020-06-03 4 M 0 6365 25.73 A 6365 D Common Stock 2020-06-03 4 S 0 6365 59.1437 D 0 D Common Stock 2020-06-05 4 M 0 5635 25.73 A 5635 D Common Stock 2020-06-05 4 S 0 5635 55.9004 D 0 D Stock Option (Right to Buy) 25.73 2020-06-03 4 M 0 6365 0.00 D 2028-05-16 Common Stock 6365 5635 D Stock Option (Right to Buy) 25.73 2020-06-05 4 M 0 5635 0.00 D 2028-05-16 Common Stock 5635 0 D The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $59.00 to $59.34, inclusive. The reporting person undertakes to provide to Deciphera Pharmaceuticals, Inc., any security holder of Deciphera Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $55.09 to $56.00, inclusive. The reporting person undertakes to provide to Deciphera Pharmaceuticals, Inc., any security holder of Deciphera Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. This stock option award was issued pursuant to Issuer's 2017 Stock Option and Incentive Plan and vested in full on May 17, 2019, subject to the Reporting Person's continuous service with the Issuer. /s/ Thomas P. Kelly, Attorney-in-Fact 2020-06-05